NBIX icon

Neurocrine Biosciences

198 hedge funds and large institutions have $3.98B invested in Neurocrine Biosciences in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 52 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$61.7M
Puts
$18.9M
Net Calls
Net Calls Change

Top Buyers

1 +$67.8M
2 +$20.1M
3 +$19M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$16.6M
5
Norges Bank
Norges Bank
Norway
+$14.1M

Top Sellers

1 -$53.2M
2 -$48.4M
3 -$39.6M
4
O
OrbiMed
New York
-$35.3M
5
PA
Perceptive Advisors
New York
-$21.8M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$2.63M
102
$2.59M
103
$2.42M
104
$2.32M
105
$2.09M
106
$1.98M
107
$1.96M
108
$1.96M
109
$1.92M
110
$1.92M
111
$1.86M
112
$1.8M
113
$1.72M
114
$1.71M
115
$1.69M
116
$1.58M
117
$1.47M
118
$1.47M
119
$1.37M
120
$1.28M
121
$1.24M
122
$1.21M
123
$1.2M
124
$1.17M
125
$1.17M